Recently, a bispecific antibody targeting hERG and the β1 subunit of integrin receptors, which form a specific multimeric complex in tumor cells, was shown to reduce growth and vascularization in various solid tumor models, whereas it did not bind to the hERG1 channel in healthy tissues, including the heart [43]. This evidence concerns the gene KCNH2 and neoplasm.